Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05746143
PHASE4
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
Sponsor: University of Southern California
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.
Official title: The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion: A Randomized Control Trial
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2022-02-01
Completion Date
2027-12-31
Last Updated
2024-06-25
Healthy Volunteers
No
Interventions
DRUG
Zolpidem Tartrate 10 mg
two days preoperatively and five days postoperatively
DRUG
Placebo
two days preoperatively and five days postoperatively
Locations (1)
Keck Medical Center of USC
Los Angeles, California, United States